Building Better Quality Products: Quality Control and Assurance

19 Jan 2023
Manufacturing Advanced Therapies Track

11:00am Chair Introduction

Cynthia Pussinen, Chief Technology Officer, Spark Therapeutics


11:05am Presentation: TBA

Azadeh Golipour, Chief Technical Officer, AVROBIO


11:20am Presentation: Implementing A 1-hour Mycoplasma Test for Immune-Effector Cells

  • Addressing the current challenges faced in product release
  • Benefits of an ultra-rapid and simplified assay to face scarcity of highly skilled workforce
  • Validation approach for multiple products

Zankar Desai, Assistant Technical Director, Cell Therapy Testing Lab, Dana-Farber Cancer Institute


11:35am Presentation: TBA

Senior Representative, Triumvira Immunologics


11:50am Presentation: TBA

Senior Representative, Accellix


12:05pm Closing Panel with Q&A

With all session participants, Joined by: 

Eric Hacherl, Vice President, Head of Manufacturing, Spark Therapeutics


Azadeh Golipour
Chief Technical Officer
Cynthia Pussinen
Chief Technical Officer
Spark Therapeutics
Eric Hacherl
Vice President, Head of Manufacturing
Spark Therapeutics
Zankar Desai
Assistant Technical Director, Cell Therapy Testing Lab
Dana-Farber Cancer Institute